Skip to main content
Clinical Trials/CTRI/2024/07/069807
CTRI/2024/07/069807
Not yet recruiting
Phase 3

Comparative clinical evaluation of sub epithelial connective tissue graft SCTG and xenogenic collagen matrix in treatment of Miller s class I and class II gingival recession A randomized split mouth control trial - nil

Vinitha V0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vinitha V
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Vinitha V

Eligibility Criteria

Inclusion Criteria

  • 1 Patients with age of \=18 years
  • 2 Patients have to display at least one buccal recession(bilaterally) classified as Miller s class I or II with no visible loss of interdental hard and soft tissues
  • 3 Probing pocket depth \<3mm
  • 4 No prior history of any surgical procedures on the site to be treated
  • 5 Presence of detectable CEJ
  • 6 Systemically healthy subjects with no contraindication to periodontal surgery
  • 7 Able to achieve good oral hygiene and control gingivitis in the whole of the dentition
  • 8 Patient willing to undergo surgical procedure with written informed consent
  • 9 No permanent medication in the last 6 months

Exclusion Criteria

  • 1 Persistence of uncorrected gingival trauma from tooth brushing
  • 2 Presence of severe tooth malposition rotation or clinically significant supra\-eruption
  • 3 Cervical or root caries cervical abrasion prosthetic crown and restorations involving cemento\-enamel junction
  • 4 Pregnant and lactating mothers
  • 5 Hypersensitivity or allergy to the collagen based medical product
  • 6 Patients using smoked and smokeless form of tobacco for atleast 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials